Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$37.5M Sell
480,925
-10,134
-2% -$754K 0.04% 447
2023
Q4
$35.1M Sell
491,059
-380,347
-44% -$26.5M 0.03% 485
2023
Q3
$60.5M Sell
871,406
-31,232
-3% -$2.36M 0.06% 330
2023
Q2
$73.1M Sell
902,638
-41,165
-4% -$3.36M 0.07% 283
2023
Q1
$76.2M Sell
943,803
-51,767
-5% -$4.17M 0.08% 257
2022
Q4
$74.5M Buy
995,570
+77,428
+8% +$5.51M 0.08% 268
2022
Q3
$59.2M Buy
918,142
+69,196
+8% +$4.79M 0.07% 318
2022
Q2
$58.8M Buy
848,946
+357,710
+73% +$26.6M 0.06% 332
2022
Q1
$37.7M Buy
491,236
+5,354
+1% +$385K 0.03% 554
2021
Q4
$37.2M Buy
485,882
+833
+0.2% +$61.2K 0.02% 782
2021
Q3
$35.8M Sell
485,049
-81,302
-14% -$6.1M 0.02% 791
2021
Q2
$37.8M Sell
566,351
-44,051
-7% -$2.94M 0.02% 821
2021
Q1
$45.4M Buy
610,402
+49,546
+9% +$3.76M 0.02% 751
2020
Q4
$40.8M Buy
560,856
+64,680
+13% +$4.57M 0.02% 808
2020
Q3
$33M Buy
496,176
+80,006
+19% +$5.06M 0.02% 787
2020
Q2
$23.7M Sell
416,170
-28,485
-6% -$1.4M 0.02% 863
2020
Q1
$15.6M Sell
444,655
-103,832
-19% -$4.94M 0.01% 954
2019
Q4
$28.6M Buy
548,487
+38,010
+7% +$1.89M 0.02% 834
2019
Q3
$25.8M Sell
510,477
-29,836
-6% -$1.47M 0.02% 767
2019
Q2
$25.9M Buy
540,313
+148,109
+38% +$6.85M 0.02% 778
2019
Q1
$19M Sell
392,204
-25,063
-6% -$1.13M 0.02% 894
2018
Q4
$17.1M Buy
417,267
+62,470
+18% +$2.56M 0.02% 871
2018
Q3
$14.5M Buy
354,797
+95,405
+37% +$3.86M 0.01% 1047
2018
Q2
$10.3M Sell
259,392
-108,177
-29% -$4.16M 0.01% 1225
2018
Q1
$13.7M Sell
367,569
-36,139
-9% -$1.46M 0.01% 1065
2017
Q4
$17.3M Sell
403,708
-34,767
-8% -$1.39M 0.02% 968
2017
Q3
$16.1M Sell
438,475
-83,041
-16% -$3.35M 0.02% 962
2017
Q2
$23.7M Sell
521,516
-70,050
-12% -$3.09M 0.02% 721
2017
Q1
$25.2M Buy
591,566
+58,416
+11% +$2.38M 0.02% 709
2016
Q4
$21.4M Buy
533,150
+20,103
+4% +$776K 0.02% 772
2016
Q3
$19.9M Buy
513,047
+1,791
+0.4% +$67.6K 0.02% 822
2016
Q2
$17.7M Sell
511,256
-920,533
-64% -$31.9M 0.02% 823
2016
Q1
$49.4M Buy
1,431,789
+811,258
+131% +$28.3M 0.06% 346
2015
Q4
$24M Buy
620,531
+250,657
+68% +$9.75M 0.03% 670
2015
Q3
$14.5M Sell
369,874
-20,356
-5% -$807K 0.02% 916
2015
Q2
$14.9M Sell
390,230
-3,504
-0.9% -$123K 0.01% 1001
2015
Q1
$13M Sell
393,734
-28,609
-7% -$878K 0.01% 1048
2014
Q4
$11.3M Sell
422,343
-194,379
-32% -$5.02M 0.01% 1193
2014
Q3
$15M Buy
616,722
+15,488
+3% +$391K 0.01% 1066
2014
Q2
$15.2M Buy
601,234
+69,909
+13% +$1.63M 0.01% 1111
2014
Q1
$11.4M Buy
531,325
+44,889
+9% +$968K 0.01% 1161
2013
Q4
$10.9M Buy
486,436
+77,340
+19% +$1.71M 0.01% 1208
2013
Q3
$8.45M Sell
409,096
-351,221
-46% -$7.48M 0.01% 1241
2013
Q2
$14.7M Buy
+760,317
New +$15.9M 0.01% 916

Other funds holding HOLX

Credit Suisse's HOLX Position: Q1 2024 in Review

Credit Suisse reduced its Hologic (HOLX) stake by 2.1% in Q1 2024, selling an estimated $754K and leaving 480,925 shares worth $37.5M. The position accounts for 0.04% of the portfolio, ranked #447.

Credit Suisse first reported a position in HOLX in Q2 2013 and has held it in 44 quarters since. The position peaked at $76.2M in Q1 2023. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Credit Suisse held 480,925 shares of Hologic worth $37.5M as of Q1 2024.
  • Credit Suisse sold 10,134 Hologic shares in Q1 2024, an estimated $754K.
  • Hologic made up 0.04% of Credit Suisse's portfolio in Q1 2024, its #447 holding.
  • Credit Suisse first reported a position in Hologic in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Hologic position peaked at $76.2M in Q1 2023.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.